Leflunomide to Prevent Cytomegalovirus Reactivation in Stem Cell Transplant Patients
Clinical trial NCT07709013 · RECRUITING
Trial details
- NCT number
- NCT07709013
- Sponsor
- Tata Memorial Centre
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-18
- Primary completion
- 2029-04-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.